Suppr超能文献

血液系统恶性肿瘤患儿脑脊液中的低分子量血浆蛋白

Low molecular weight plasma proteins in the cerebrospinal fluid of children with hematological malignancies.

作者信息

Duggan M B, Whittaker J A, Cooper E H, Bailey C C, Robinson E A

出版信息

Med Pediatr Oncol. 1984;12(2):131-6. doi: 10.1002/mpo.2950120215.

Abstract

The concentration of beta-2-microglobulin (beta 2-m) and of post gamma globulin (P gamma G) was examined in serum and cerebrospinal fluid from children with acute lymphatic leukemia (ALL) and non-Hodgkin's lymphoma (NHL). Data were analysed in order to determine whether concentration of beta 2-m or P gamma G during remission would be of value in predicting relapse or eventual outcome. Mean serum concentration of beta 2-m was similar in good and poor prognosis patients with ALL in remission and was not significantly altered in CNS or marrow relapse. Mean CSF concentration in NHL was also similar in both prognostic groups, and in poor prognosis patients was not significantly altered in relapse. The same pattern was seen when P gamma G was measured in CSF (serum concentration of this protein being too low for accurate determination). High within patient variability of levels of beta 2-m and P gamma G appeared to relate to chemotherapy rather than the disease process. Concentration of P gamma G was persistently raised in three children with brain damage of differing etiologies. Levels of two other low molecular weight proteins, retinol binding protein and alpha 1-microglobulin, were also determined in order to establish that beta 2-m and P gamma G concentration was not influenced by alteration in permeability of the blood-brain barrier. The beta 2-m and P gamma G concentration, although higher than reported in healthy children [5] does not appear to be of value as a prognostic indicator in ALL and NHL in children.

摘要

对急性淋巴细胞白血病(ALL)和非霍奇金淋巴瘤(NHL)患儿的血清和脑脊液中的β2-微球蛋白(β2-m)和γ球蛋白后体(PγG)浓度进行了检测。对数据进行分析,以确定缓解期β2-m或PγG的浓度是否对预测复发或最终结局有价值。缓解期预后良好和预后不良的ALL患者的血清β2-m平均浓度相似,在中枢神经系统(CNS)或骨髓复发时无明显变化。两个预后组的NHL患者脑脊液平均浓度也相似,预后不良患者复发时无明显变化。当检测脑脊液中的PγG时也出现了同样的模式(该蛋白的血清浓度过低,无法准确测定)。β2-m和PγG水平在患者体内的高变异性似乎与化疗有关,而非疾病进程。三名病因不同的脑损伤患儿的PγG浓度持续升高。还测定了另外两种低分子量蛋白,视黄醇结合蛋白和α1-微球蛋白的水平,以确定β2-m和PγG浓度不受血脑屏障通透性改变的影响。β2-m和PγG浓度虽然高于健康儿童的报道水平[5],但似乎对儿童ALL和NHL的预后没有预测价值。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验